The Relationship between the Incidence of Atrial Fibrillation and Patients with Type 2 Diabetes Mellitus: A Systematic Review

Mohammed Abdulrahman Al-Falah, Y. Medany, Mansoor Alnaim, Mareyah Alshaikh Husain, Mariam Sami Alshehab, Y. Al-Mulhim, J. AlRashada, A. Alarfaj, S. A. Almulhim, Abdulaziz Ali Alyousof, Hesham Alsuqair, Munirah Aldawsari
{"title":"The Relationship between the Incidence of Atrial Fibrillation and Patients with Type 2 Diabetes Mellitus: A Systematic Review","authors":"Mohammed Abdulrahman Al-Falah, Y. Medany, Mansoor Alnaim, Mareyah Alshaikh Husain, Mariam Sami Alshehab, Y. Al-Mulhim, J. AlRashada, A. Alarfaj, S. A. Almulhim, Abdulaziz Ali Alyousof, Hesham Alsuqair, Munirah Aldawsari","doi":"10.36348/sjmps.2024.v10i04.002","DOIUrl":null,"url":null,"abstract":"Objectives: To investigate the prevalence and mechanisms of atrial fibrillation (AF) among type 2 diabetes (T2D) patients. Methods: We conducted a thorough search of PubMed, SCOPUS, Web of Science, Google Scholar, and Science Direct to find pertinent literature. Rayyan QRCI was utilized during the entire process. Results: We included twelve studies with a total of 587,822 T2D patients and 299,957 (51%) were females. The prevalence of AF among T2D patients ranged from 0.2% to 41.63% with a total prevalence of 44936 (7.6%). The reported risk factors for developing AF among T2D patients were impaired glucose tolerance (IGT), men, obesity, elderly patients, those with lower socioeconomic backgrounds, those who currently smoked, people with reduced renal function, long-term BP fluctuation, and microvascular illness. Conclusion: Although the exact relationship between T2D and AF is still unclear, there is a significant correlation. Certain glycemic control studies indicate that therapeutic HbA1c levels in conjunction with well-controlled T2D do not significantly reduce the risk of new-onset AF in T2D patients. Further investigation is needed to fully comprehend the connection between T2D and AF. In the interim, healthcare professionals can treat people with T2D, AF, or possibly both illnesses at the same time according to accepted guidelines.","PeriodicalId":21367,"journal":{"name":"Saudi Journal of Medical and Pharmaceutical Sciences","volume":"26 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Saudi Journal of Medical and Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36348/sjmps.2024.v10i04.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: To investigate the prevalence and mechanisms of atrial fibrillation (AF) among type 2 diabetes (T2D) patients. Methods: We conducted a thorough search of PubMed, SCOPUS, Web of Science, Google Scholar, and Science Direct to find pertinent literature. Rayyan QRCI was utilized during the entire process. Results: We included twelve studies with a total of 587,822 T2D patients and 299,957 (51%) were females. The prevalence of AF among T2D patients ranged from 0.2% to 41.63% with a total prevalence of 44936 (7.6%). The reported risk factors for developing AF among T2D patients were impaired glucose tolerance (IGT), men, obesity, elderly patients, those with lower socioeconomic backgrounds, those who currently smoked, people with reduced renal function, long-term BP fluctuation, and microvascular illness. Conclusion: Although the exact relationship between T2D and AF is still unclear, there is a significant correlation. Certain glycemic control studies indicate that therapeutic HbA1c levels in conjunction with well-controlled T2D do not significantly reduce the risk of new-onset AF in T2D patients. Further investigation is needed to fully comprehend the connection between T2D and AF. In the interim, healthcare professionals can treat people with T2D, AF, or possibly both illnesses at the same time according to accepted guidelines.
心房颤动发病率与 2 型糖尿病患者之间的关系:系统回顾
目的研究 2 型糖尿病(T2D)患者心房颤动(AF)的发病率和机制。方法我们对 PubMed、SCOPUS、Web of Science、Google Scholar 和 Science Direct 进行了全面搜索,以查找相关文献。整个过程中使用了 Rayyan QRCI。结果我们共纳入了 12 项研究,涉及 587,822 名 T2D 患者,其中 299,957 人(51%)为女性。房颤在 T2D 患者中的发病率从 0.2% 到 41.63% 不等,总发病率为 44936 例(7.6%)。据报道,糖耐量受损(IGT)、男性、肥胖、老年患者、社会经济背景较差者、吸烟者、肾功能减退者、长期血压波动和微血管疾病是 T2D 患者发生房颤的风险因素。结论虽然 T2D 与房颤之间的确切关系尚不明确,但两者之间存在显著的相关性。某些血糖控制研究表明,治疗性 HbA1c 水平与控制良好的 T2D 结合使用,并不能显著降低 T2D 患者新发房颤的风险。要完全理解 T2D 与房颤之间的联系,还需要进一步的研究。在此期间,医护人员可以根据公认的指南,对患有 T2D、房颤或可能同时患有这两种疾病的患者进行治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信